ROYAL BANK OF CANADA - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$0850.0%0.00%
Q4 2022$0850.0%0.00%
Q3 2022$085
-40.6%
0.00%
Q2 2022$0
-100.0%
143
-92.7%
0.00%
Q1 2022$5,000
-83.9%
1,959
-70.4%
0.00%
Q4 2021$31,000
+14.8%
6,625
+113.6%
0.00%
Q3 2021$27,000
-25.0%
3,102
+37.7%
0.00%
Q2 2021$36,000
-29.4%
2,253
-1.3%
0.00%
Q1 2021$51,000
+131.8%
2,283
+222.9%
0.00%
Q4 2020$22,000
+2100.0%
707
+2180.6%
0.00%
Q3 2020$1,00031
+29.2%
0.00%
Q2 2020$0
-100.0%
24
-91.3%
0.00%
Q1 2020$2,000
-86.7%
276
-74.3%
0.00%
Q4 2019$15,000
+1400.0%
1,074
+1817.9%
0.00%
Q3 2019$1,000560.00%
Other shareholders

There were no reported owners of TCR2 THERAPEUTICS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of TCR2 THERAPEUTICS INC shareholders